Skip to content

Clinical trials

Rare Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Country / region: Canada Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20131
20161
20171
20181
20191
20222
20232
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status4
Recruiting4
Terminated2
Active, not recruiting2
Withdrawn1
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)4
Friedreich's Ataxia Research Alliance2
Novartis Pharmaceuticals2
REGENXBIO Inc.2
Gemma Biotherapeutics1
Hanns Lochmuller1
Holland Bloorview Kids Rehabilitation Hospital1
Kyowa Kirin Co., Ltd.1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
NightstaRx Ltd, a Biogen Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases22
Genetic Diseases, Inborn4
Communicable Diseases3
Immune System Diseases3
Metabolic Diseases3
Neurodegenerative Diseases3
Neurologic Manifestations3
Atherosclerosis2
Cardiovascular Diseases2
Friedreich Ataxia2

Trials

Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.